0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Embolization Particle Market Research Report 2026
Published Date: 2026-01-15
|
Report Code: QYRE-Auto-33P8693
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Embolization Particle Market Outlook 2022
BUY CHAPTERS

Global Embolization Particle Market Research Report 2026

Code: QYRE-Auto-33P8693
Report
2026-01-15
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Embolization Particle Market Size

The global Embolization Particle market was valued at US$ 2977 million in 2025 and is anticipated to reach US$ 7584 million by 2032, at a CAGR of 14.5% from 2026 to 2032.

Embolization Particle Market

Embolization Particle Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Embolization Particle competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
This report delivers a comprehensive overview of the global Embolization Particle market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Embolization Particle. The Embolization Particle market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Embolization Particle market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Embolization Particle manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Embolization Particle Market Report

Report Metric Details
Report Name Embolization Particle Market
Accounted market size in 2025 US$ 2977 million
Forecasted market size in 2032 US$ 7584 million
CAGR 14.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Microspheres
  • Particles (e.g. PVA Particles, Gelfoam Particles)
  • Drug-eluting Beads (DEBs)
  • Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
by Application
  • Uterine Fibroid Embolization
  • Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
  • Liver Tumor Embolization
  • Trauma Embolization
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V., Alicon
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Embolization Particle manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Embolization Particle sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Embolization Particle Market growing?

Ans: The Embolization Particle Market witnessing a CAGR of 14.5% during the forecast period 2026-2032.

What is the Embolization Particle Market size in 2032?

Ans: The Embolization Particle Market size in 2032 will be US$ 7584 million.

What is the Embolization Particle Market share by region?

Ans: North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%.

What is the market share of major companies in Embolization Particle Market?

Ans: Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.

Who are the main players in the Embolization Particle Market report?

Ans: The main players in the Embolization Particle Market are Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V., Alicon

What are the Application segmentation covered in the Embolization Particle Market report?

Ans: The Applications covered in the Embolization Particle Market report are Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization, Trauma Embolization, Others

What are the Type segmentation covered in the Embolization Particle Market report?

Ans: The Types covered in the Embolization Particle Market report are Microspheres, Particles (e.g. PVA Particles, Gelfoam Particles), Drug-eluting Beads (DEBs), Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

1 Embolization Particle Market Overview
1.1 Product Definition
1.2 Embolization Particle by Type
1.2.1 Global Embolization Particle Market Value by Type: 2025 vs 2032
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Embolization Particle by Application
1.3.1 Global Embolization Particle Market Value by Application: 2025 vs 2032
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Global Embolization Particle Market Size Estimates and Forecasts
1.4.1 Global Embolization Particle Revenue 2021–2032
1.4.2 Global Embolization Particle Sales 2021–2032
1.4.3 Global Embolization Particle Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Embolization Particle Market Competition by Manufacturers
2.1 Global Embolization Particle Sales Market Share by Manufacturers (2021–2026)
2.2 Global Embolization Particle Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Embolization Particle Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Embolization Particle, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Embolization Particle, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Embolization Particle, Product Types and Applications
2.7 Global Key Manufacturers of Embolization Particle, Date of Entry into the Industry
2.8 Global Embolization Particle Market Competitive Situation and Trends
2.8.1 Global Embolization Particle Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Embolization Particle Players Market Share by Revenue
2.8.3 Global Embolization Particle Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Embolization Particle Market Scenario by Region
3.1 Global Embolization Particle Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Embolization Particle Sales by Region: 2021–2032
3.2.1 Global Embolization Particle Sales by Region: 2021–2026
3.2.2 Global Embolization Particle Sales by Region: 2027–2032
3.3 Global Embolization Particle Revenue by Region: 2021–2032
3.3.1 Global Embolization Particle Revenue by Region: 2021–2026
3.3.2 Global Embolization Particle Revenue by Region: 2027–2032
3.4 North America Embolization Particle Market Facts & Figures by Country
3.4.1 North America Embolization Particle Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Embolization Particle Sales by Country (2021–2032)
3.4.3 North America Embolization Particle Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Embolization Particle Market Facts & Figures by Country
3.5.1 Europe Embolization Particle Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Embolization Particle Sales by Country (2021–2032)
3.5.3 Europe Embolization Particle Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Embolization Particle Market Facts & Figures by Region
3.6.1 Asia Pacific Embolization Particle Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Embolization Particle Sales by Region (2021–2032)
3.6.3 Asia Pacific Embolization Particle Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Embolization Particle Market Facts & Figures by Country
3.7.1 Latin America Embolization Particle Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Embolization Particle Sales by Country (2021–2032)
3.7.3 Latin America Embolization Particle Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Embolization Particle Market Facts & Figures by Country
3.8.1 Middle East and Africa Embolization Particle Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Embolization Particle Sales by Country (2021–2032)
3.8.3 Middle East and Africa Embolization Particle Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Embolization Particle Sales by Type (2021–2032)
4.1.1 Global Embolization Particle Sales by Type (2021–2026)
4.1.2 Global Embolization Particle Sales by Type (2027–2032)
4.1.3 Global Embolization Particle Sales Market Share by Type (2021–2032)
4.2 Global Embolization Particle Revenue by Type (2021–2032)
4.2.1 Global Embolization Particle Revenue by Type (2021–2026)
4.2.2 Global Embolization Particle Revenue by Type (2027–2032)
4.2.3 Global Embolization Particle Revenue Market Share by Type (2021–2032)
4.3 Global Embolization Particle Price by Type (2021–2032)
5 Segment by Application
5.1 Global Embolization Particle Sales by Application (2021–2032)
5.1.1 Global Embolization Particle Sales by Application (2021–2026)
5.1.2 Global Embolization Particle Sales by Application (2027–2032)
5.1.3 Global Embolization Particle Sales Market Share by Application (2021–2032)
5.2 Global Embolization Particle Revenue by Application (2021–2032)
5.2.1 Global Embolization Particle Revenue by Application (2021–2026)
5.2.2 Global Embolization Particle Revenue by Application (2027–2032)
5.2.3 Global Embolization Particle Revenue Market Share by Application (2021–2032)
5.3 Global Embolization Particle Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sirtex Medical
6.1.1 Sirtex Medical Company Information
6.1.2 Sirtex Medical Description and Business Overview
6.1.3 Sirtex Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sirtex Medical Embolization Particle Product Portfolio
6.1.5 Sirtex Medical Recent Developments/Updates
6.2 Merit Medical
6.2.1 Merit Medical Company Information
6.2.2 Merit Medical Description and Business Overview
6.2.3 Merit Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merit Medical Embolization Particle Product Portfolio
6.2.5 Merit Medical Recent Developments/Updates
6.3 Cook Medical
6.3.1 Cook Medical Company Information
6.3.2 Cook Medical Description and Business Overview
6.3.3 Cook Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Cook Medical Embolization Particle Product Portfolio
6.3.5 Cook Medical Recent Developments/Updates
6.4 BTG Medical
6.4.1 BTG Medical Company Information
6.4.2 BTG Medical Description and Business Overview
6.4.3 BTG Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BTG Medical Embolization Particle Product Portfolio
6.4.5 BTG Medical Recent Developments/Updates
6.5 Boston Scientific Corporation
6.5.1 Boston Scientific Corporation Company Information
6.5.2 Boston Scientific Corporation Description and Business Overview
6.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Boston Scientific Corporation Embolization Particle Product Portfolio
6.5.5 Boston Scientific Corporation Recent Developments/Updates
6.6 Terumo Corporation
6.6.1 Terumo Corporation Company Information
6.6.2 Terumo Corporation Description and Business Overview
6.6.3 Terumo Corporation Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Terumo Corporation Embolization Particle Product Portfolio
6.6.5 Terumo Corporation Recent Developments/Updates
6.7 HENGRUI Medical
6.7.1 HENGRUI Medical Company Information
6.7.2 HENGRUI Medical Description and Business Overview
6.7.3 HENGRUI Medical Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 HENGRUI Medical Embolization Particle Product Portfolio
6.7.5 HENGRUI Medical Recent Developments/Updates
6.8 INterface BIOmaterials B.V.
6.8.1 INterface BIOmaterials B.V. Company Information
6.8.2 INterface BIOmaterials B.V. Description and Business Overview
6.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
6.8.5 INterface BIOmaterials B.V. Recent Developments/Updates
6.9 Alicon
6.9.1 Alicon Company Information
6.9.2 Alicon Description and Business Overview
6.9.3 Alicon Embolization Particle Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Alicon Embolization Particle Product Portfolio
6.9.5 Alicon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Embolization Particle Industry Chain Analysis
7.2 Embolization Particle Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Embolization Particle Production Mode & Process Analysis
7.4 Embolization Particle Sales and Marketing
7.4.1 Embolization Particle Sales Channels
7.4.2 Embolization Particle Distributors
7.5 Embolization Particle Customer Analysis
8 Embolization Particle Market Dynamics
8.1 Embolization Particle Industry Trends
8.2 Embolization Particle Market Drivers
8.3 Embolization Particle Market Challenges
8.4 Embolization Particle Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Embolization Particle Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Embolization Particle Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Embolization Particle Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Embolization Particle Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Embolization Particle Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Embolization Particle Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Embolization Particle Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Embolization Particle Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Embolization Particle, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Embolization Particle, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Embolization Particle, Product Types and Applications
 Table 12. Global Key Manufacturers of Embolization Particle, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Embolization Particle Companies by Tier (Tier 1, Tier 2, Tier 3), based on Embolization Particle Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Embolization Particle Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Embolization Particle Sales by Region (K Units), 2021–2026
 Table 18. Global Embolization Particle Sales Market Share by Region (2021–2026)
 Table 19. Global Embolization Particle Sales by Region (K Units), 2027–2032
 Table 20. Global Embolization Particle Sales Market Share by Region (2027–2032)
 Table 21. Global Embolization Particle Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Embolization Particle Revenue Market Share by Region (2021–2026)
 Table 23. Global Embolization Particle Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Embolization Particle Revenue Market Share by Region (2027–2032)
 Table 25. North America Embolization Particle Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Embolization Particle Sales by Country (K Units), 2021–2026
 Table 27. North America Embolization Particle Sales by Country (K Units), 2027–2032
 Table 28. North America Embolization Particle Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Embolization Particle Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Embolization Particle Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Embolization Particle Sales by Country (K Units), 2021–2026
 Table 32. Europe Embolization Particle Sales by Country (K Units), 2027–2032
 Table 33. Europe Embolization Particle Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Embolization Particle Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Embolization Particle Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Embolization Particle Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Embolization Particle Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Embolization Particle Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Embolization Particle Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Embolization Particle Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Embolization Particle Sales by Country (K Units), 2021–2026
 Table 42. Latin America Embolization Particle Sales by Country (K Units), 2027–2032
 Table 43. Latin America Embolization Particle Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Embolization Particle Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Embolization Particle Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Embolization Particle Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Embolization Particle Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Embolization Particle Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Embolization Particle Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Embolization Particle Sales (K Units) by Type (2021–2026)
 Table 51. Global Embolization Particle Sales (K Units) by Type (2027–2032)
 Table 52. Global Embolization Particle Sales Market Share by Type (2021–2026)
 Table 53. Global Embolization Particle Sales Market Share by Type (2027–2032)
 Table 54. Global Embolization Particle Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Embolization Particle Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Embolization Particle Revenue Market Share by Type (2021–2026)
 Table 57. Global Embolization Particle Revenue Market Share by Type (2027–2032)
 Table 58. Global Embolization Particle Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Embolization Particle Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Embolization Particle Sales (K Units) by Application (2021–2026)
 Table 61. Global Embolization Particle Sales (K Units) by Application (2027–2032)
 Table 62. Global Embolization Particle Sales Market Share by Application (2021–2026)
 Table 63. Global Embolization Particle Sales Market Share by Application (2027–2032)
 Table 64. Global Embolization Particle Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Embolization Particle Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Embolization Particle Revenue Market Share by Application (2021–2026)
 Table 67. Global Embolization Particle Revenue Market Share by Application (2027–2032)
 Table 68. Global Embolization Particle Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Embolization Particle Price (USD/Unit) by Application (2027–2032)
 Table 70. Sirtex Medical Company Information
 Table 71. Sirtex Medical Description and Business Overview
 Table 72. Sirtex Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Sirtex Medical Embolization Particle Product
 Table 74. Sirtex Medical Recent Developments/Updates
 Table 75. Merit Medical Company Information
 Table 76. Merit Medical Description and Business Overview
 Table 77. Merit Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Merit Medical Embolization Particle Product
 Table 79. Merit Medical Recent Developments/Updates
 Table 80. Cook Medical Company Information
 Table 81. Cook Medical Description and Business Overview
 Table 82. Cook Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Cook Medical Embolization Particle Product
 Table 84. Cook Medical Recent Developments/Updates
 Table 85. BTG Medical Company Information
 Table 86. BTG Medical Description and Business Overview
 Table 87. BTG Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. BTG Medical Embolization Particle Product
 Table 89. BTG Medical Recent Developments/Updates
 Table 90. Boston Scientific Corporation Company Information
 Table 91. Boston Scientific Corporation Description and Business Overview
 Table 92. Boston Scientific Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Boston Scientific Corporation Embolization Particle Product
 Table 94. Boston Scientific Corporation Recent Developments/Updates
 Table 95. Terumo Corporation Company Information
 Table 96. Terumo Corporation Description and Business Overview
 Table 97. Terumo Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Terumo Corporation Embolization Particle Product
 Table 99. Terumo Corporation Recent Developments/Updates
 Table 100. HENGRUI Medical Company Information
 Table 101. HENGRUI Medical Description and Business Overview
 Table 102. HENGRUI Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. HENGRUI Medical Embolization Particle Product
 Table 104. HENGRUI Medical Recent Developments/Updates
 Table 105. INterface BIOmaterials B.V. Company Information
 Table 106. INterface BIOmaterials B.V. Description and Business Overview
 Table 107. INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. INterface BIOmaterials B.V. Embolization Particle Product
 Table 109. INterface BIOmaterials B.V. Recent Developments/Updates
 Table 110. Alicon Company Information
 Table 111. Alicon Description and Business Overview
 Table 112. Alicon Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Alicon Embolization Particle Product
 Table 114. Alicon Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Embolization Particle Distributors List
 Table 118. Embolization Particle Customers List
 Table 119. Embolization Particle Market Trends
 Table 120. Embolization Particle Market Drivers
 Table 121. Embolization Particle Market Challenges
 Table 122. Embolization Particle Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Embolization Particle
 Figure 2. Global Embolization Particle Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Embolization Particle Market Share by Type: 2025 & 2032
 Figure 4. Microspheres Product Picture
 Figure 5. Particles (e.g. PVA Particles, Gelfoam Particles) Product Picture
 Figure 6. Drug-eluting Beads (DEBs) Product Picture
 Figure 7. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Product Picture
 Figure 8. Global Embolization Particle Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Embolization Particle Market Share by Application: 2025 & 2032
 Figure 10. Uterine Fibroid Embolization
 Figure 11. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
 Figure 12. Liver Tumor Embolization
 Figure 13. Trauma Embolization
 Figure 14. Others
 Figure 15. Global Embolization Particle Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Embolization Particle Market Size (US$ Million), 2021–2032
 Figure 17. Global Embolization Particle Sales (K Units), 2021–2032
 Figure 18. Global Embolization Particle Average Price (USD/Unit), 2021–2032
 Figure 19. Embolization Particle Report Years Considered
 Figure 20. Embolization Particle Sales Share by Manufacturers in 2025
 Figure 21. Global Embolization Particle Revenue Share by Manufacturers in 2025
 Figure 22. Top 5 and Top 10 Global Embolization Particle Players: Market Share by Revenue in Embolization Particle in 2025
 Figure 23. Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 24. Global Embolization Particle Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 25. North America Embolization Particle Sales Market Share by Country (2021–2032)
 Figure 26. North America Embolization Particle Revenue Market Share by Country (2021–2032)
 Figure 27. U.S. Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Canada Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Europe Embolization Particle Sales Market Share by Country (2021–2032)
 Figure 30. Europe Embolization Particle Revenue Market Share by Country (2021–2032)
 Figure 31. Germany Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. France Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. U.K. Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Italy Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Russia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Asia Pacific Embolization Particle Sales Market Share by Region (2021–2032)
 Figure 37. Asia Pacific Embolization Particle Revenue Market Share by Region (2021–2032)
 Figure 38. China Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Japan Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. South Korea Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. India Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Australia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Taiwan Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Indonesia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Thailand Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Malaysia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Philippines Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Latin America Embolization Particle Sales Market Share by Country (2021–2032)
 Figure 49. Latin America Embolization Particle Revenue Market Share by Country (2021–2032)
 Figure 50. Mexico Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Brazil Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Argentina Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Middle East and Africa Embolization Particle Sales Market Share by Country (2021–2032)
 Figure 54. Middle East and Africa Embolization Particle Revenue Market Share by Country (2021–2032)
 Figure 55. Turkey Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Saudi Arabia Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. U.A.E Embolization Particle Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Global Sales Market Share of Embolization Particle by Type (2021–2032)
 Figure 59. Global Revenue Market Share of Embolization Particle by Type (2021–2032)
 Figure 60. Global Embolization Particle Price (USD/Unit) by Type (2021–2032)
 Figure 61. Global Sales Market Share of Embolization Particle by Application (2021–2032)
 Figure 62. Global Revenue Market Share of Embolization Particle by Application (2021–2032)
 Figure 63. Global Embolization Particle Price (USD/Unit) by Application (2021–2032)
 Figure 64. Embolization Particle Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture